With COVID-19 interrupting some 70% of ongoing clinical trials, RGP Healthcare’s Marcia Brown-Rayford says that pharmaceuticals need to adopt more efficient processes—including greater use of telemedicine— to make the search for life-saving cures faster and more efficient while not sacrificing needed regulatory controls.
Read More